Skip to main content
. 2021 Sep 22;11:18812. doi: 10.1038/s41598-021-98216-0

Figure 4.

Figure 4

Outcomes of cumulative incidence of (A) infection, (B) hospitalisations, and (C) mortality, and (D) the resulting impact on public health restrictions using Oxford/AstraZeneca vaccine with between-dose intervals of 3 or 12 weeks. Each light curve is a single run of the same set of parameters, according to its colour. Each thick curve is the average of the 100 single runs.